Orion Integrated Biosciences

Executive Summary

Orion Integrated Biosciences is a private biotechnology company founded in 2005 and headquartered in San Diego, California. The company specializes in biodefense and national security, leveraging a multidisciplinary team with expertise in bioinformatics, microbiology, and artificial intelligence. Orion develops analytical systems and medical countermeasures to detect and mitigate biological threats, addressing complex challenges in health, trade, and security. By integrating advanced computational tools with biological research, the company aims to provide disruptive solutions for emerging biosecurity risks. Its focus on national security applications positions it within a niche but critical sector, with potential for government and defense contracts. Despite limited public information on funding or valuation, Orion's long operational history and specialized focus suggest a steady, if low-profile, presence in the biodefense ecosystem.

Upcoming Catalysts (preview)

• Q3 2026Award of U.S. Government Biodefense Contract65% success
• Q4 2026Launch of Next-Generation Pathogen Detection Platform50% success
• Q2 2026Strategic Partnership with a Major Defense or Health Agency40% success